Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03102242
Title Atezolizumab Immunotherapy in Patients With Advanced NSCLC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital Phoenix Arizona 85054 United States Details
UCSD Moores Cancer Center La Jolla California 92037 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
EMMC Cancer Care Brewer Maine 04412 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Saint Joseph Mercy Hospital Ann Arbor Michigan 48106 United States Details
Metro MN Community Oncology Research Consortium Minneapolis Minnesota 55416 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
SUNY Upstate Medical University Syracuse New York 13210 United States Details
Ohio State University James Cancer Center Columbus Ohio 43210 United States Details
Lankenau Medical Center Wynnewood Pennsylvania 19096 United States Details
Prisma Health Greenville Memorial Hospital Greenville South Carolina 29605 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field